pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy

References

• ZhaoKLiDXuWTargeted hydroxyethyl starch prodrug for inhibiting the growth and metastasis of prostate cancerBiomaterials2017116829427914269
   PubMed Web of Science ®Google Scholar
• DesantisCESiegelRLSauerAGCancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparitiesCA Cancer J Clin201666429030826910411
   PubMed Web of Science ®Google Scholar
• XuXWuJLiuYMultifunctional envelope-type siRNA delivery nanoparticle platform for prostate cancer therapyACS Nano20171132618262728240870
   PubMed Web of Science ®Google Scholar
• FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A2006103166315632016606824
   PubMed Web of Science ®Google Scholar
• RuttalaHBChitrapriyaNKalirajKFacile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapyActa Biomater20176313514928890258
   PubMed Web of Science ®Google Scholar
• ZhangRRuYGaoYLiJMaoSLayer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancerDrug Des Devel Ther20171126312642
   PubMed Web of Science ®Google Scholar
• HuQSunWWangCGuZRecent advances of cocktail chemotherapy by combination drug delivery systemsAdv Drug Deliv Rev201698193426546751
   PubMed Web of Science ®Google Scholar
• QinSYChengYJLeiQZhangAQZhangXZCombinational strategy for high-performance cancer chemotherapyBiomaterials201817117819729698868
   PubMed Web of Science ®Google Scholar
• ZhaoLWientjesMGAuJLJlAEvaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analysesClin Cancer Res200410237994800415585635
   PubMed Web of Science ®Google Scholar
• XuWDingJXiaoCVersatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeuticBiomaterials201554728625907041
   PubMed Web of Science ®Google Scholar
• OctaviaYTocchettiCGGabrielsonKLJanssensSCrijnsHJMoensALDoxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategiesJ Mol Cell Cardiol20125261213122522465037
   PubMed Web of Science ®Google Scholar
• LiuQTriptolide and its expanding multiple pharmacological functionsInt Immunopharmacol201111337738321255694
   PubMed Web of Science ®Google Scholar
• LingDXiaHParkWpH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinomaACS Nano2014888027803925093274
   PubMed Web of Science ®Google Scholar
• SaiKLiWYChenYSTriptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.[J]Am J Chin Med201442248550324707876
   PubMed Web of Science ®Google Scholar
• WuBLuSTZhangLJZhuoRXXuHBHuangSWCodelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatmentInt J Nanomedicine2017121853186228331310
   PubMed Web of Science ®Google Scholar
• TaoXGouJZhangQSynergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticlesBiomater Sci2018671869188129808221
   PubMed Web of Science ®Google Scholar
• HuoQZhuJNiuYpH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancerInt J Nanomedicine2017128631864729270012
   PubMed Web of Science ®Google Scholar
• ZhuJNiuYLiYStimuli-responsive delivery vehicles based on mesoporous silica nanoparticles: recent advances and challengesJ Mater Chem B20165
   Web of Science ®Google Scholar
• ChengXLiDLinAFabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nano-particles for chemo-photothermal therapyInt J Nanomedicine2018133661367729983561
   PubMed Web of Science ®Google Scholar
• JinMJinGKangLChenLGaoZHuangWSmart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomesInt J Nanomedicine2018132405242629719390
   PubMed Web of Science ®Google Scholar
• WangYLvSDengMTangZChenXA charge-conversional intracellular-activated polymeric prodrug for tumor therapyPolym Chem201671222532263
   Web of Science ®Google Scholar
• CheethamAGChakrounRWMaWCuiHSelf-assembling prodrugsChem Soc Rev201746216638666329019492
   PubMed Web of Science ®Google Scholar
• ZhangJFangXLiZRedox-sensitive micelles composed of disulfide-linked Pluronic-linoleic acid for enhanced anticancer efficiency of brusatolInt J Nanomedicine20181393995629491708
   PubMed Web of Science ®Google Scholar
• LinJZhaoCLiuCRedox-responsive F127-folate/F127-disulfide bond-d-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumorsInt J Nanomedicine20181380583029445276
   PubMed Web of Science ®Google Scholar
• LiJXuRLuXHeJJinSA simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistanceInt J Nanomedicine2017128043805629138561
   PubMed Web of Science ®Google Scholar
• TanSWangGRedox-ResponsiveWGRedox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivoDrug Des Devel Ther20171135193529
   PubMed Web of Science ®Google Scholar
• WeiXWangYXiongXCodelivery of a π-π stacked dual anticancer drug combination with nanocarriers for overcoming multi-drug resistance and tumor metastasisAdv Funct Mater2016264582668280
   Web of Science ®Google Scholar
• WuWu LLinMXMagnetite nanocluster and paclitaxel-loaded charge-switchable nanohybrids for MR imaging and chemotherapyJ Mater Chem B20165
   Web of Science ®Google Scholar
• ChenSRongLLeiQA surface charge-switchable and folate modified system for co-delivery of proapoptosis peptide and p53 plasmid in cancer therapyBiomaterials20167714916326599622
   PubMed Web of Science ®Google Scholar
• ChenWLLiFTangYStepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicinInt J Nanomedicine2017124241425628652730
   PubMed Web of Science ®Google Scholar
• LimCSimTHoangNHA charge-reversible nanocarrier using PEG-PLL (-g-Ce6, DMA)-PLA for photodynamic therapyInt J Nanomedicine2017126185619628883728
   PubMed Web of Science ®Google Scholar
• FengSZhangHZhiCGaoXDNakanishiHpH-responsive charge-reversal polymer-functionalized boron nitride nanospheres for intracellular doxorubicin deliveryInt J Nanomedicine20181364165229440891
   PubMed Web of Science ®Google Scholar
• YuanYYMaoCQduXJSurface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumorAdv Mater201224405476548022886872
   PubMed Web of Science ®Google Scholar
• DengCChenXYuHA biodegradable triblock copolymer poly(ethylene glycol)-b-poly(l-lactide)-b-poly(l-lysine): Synthesis, self-assembly, and RGD peptide modificationPolymer2007481139149
   Web of Science ®Google Scholar
• HuHLiYZhouQRedox-sensitive hydroxyethyl starch-doxorubicin conjugate for tumor targeted drug deliveryACS Appl Mater Interfaces2016845308333084427791359
   PubMed Web of Science ®Google Scholar
• JiangYWangXLiuXEnhanced antiglioma efficacy of ultrahigh loading capacity paclitaxel prodrug conjugate self-assembled targeted nanoparticlesACS Appl Mater Interfaces20179121121727976583
   PubMed Web of Science ®Google Scholar
• WangFWangYCDouSXiongMHSunTMWangJDoxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cellsACS Nano2011553679369221462992
   PubMed Web of Science ®Google Scholar
• YangQWuLLiLZhouZHuangYSubcellular co-delivery of two different site-oriented payloads for tumor therapyNanoscale2017941547155828067924
   PubMed Web of Science ®Google Scholar
• SuYHuYduYRedox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapyMol Pharm20151241193120225751168
   PubMedGoogle Scholar
• duJZMaoCQYuanYYYangXZWangJTumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapyBiotechnol Adv201432478980323933109
   PubMed Web of Science ®Google Scholar
• MuraSNicolasJCouvreurPStimuli-responsive nanocarriers for drug deliveryNat Mater20131211991100324150417
   PubMed Web of Science ®Google Scholar
• duJZduXJMaoCQWangJTailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug deliveryJ Am Chem Soc201113344175601756321985458
   PubMed Web of Science ®Google Scholar
• KamalyNYameenBWuJFarokhzadOCDegradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug releaseChem Rev201611642602266326854975
   PubMed Web of Science ®Google Scholar
• HuangMZhaoKWangLDual stimuli-responsive polymer prodrugs quantitatively loaded by nanoparticles for enhanced cellular internalization and triggered drug releaseACS Appl Mater Interfaces2016818112261123627100328
   PubMed Web of Science ®Google Scholar
• HanSSLiZYZhuJYDual-pH sensitive charge-reversal polypeptide micelles for tumor-triggered targeting uptake and nuclear drug deliverySmall201511212543255425626995
   PubMed Web of Science ®Google Scholar
• LiS-X LLZhangL-JSynergetic enhancement of antitumor efficacy with charge-reversal and reduction-sensitive polymer micellesPolym Chem2016751135122
   Web of Science ®Google Scholar
• BaoYGuoYZhuangXD-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cellsMol Pharm20141193196320925102234
   PubMed Web of Science ®Google Scholar
• SunJLiuYChenYDoxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapyJ Control Release2017258435528501705
   PubMed Web of Science ®Google Scholar
• LvSTangZZhangDWell-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxelJ Control Release201419422022725220162
   PubMed Web of Science ®Google Scholar
• ChenWLLiFTangYStepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicinInt J Nanomedicine2017124241425628652730
   PubMed Web of Science ®Google Scholar